Orion Oyj B

Orion Oyj revamps its long‑term incentive plan, aligning executive rewards with 2026 growth goals while hinting at a higher dividend, all driven by Nubeqa’s strong sales and solid EBITDA margins.

Orion’s Nubeqa sales projected to top €1 billion, driven by solid phase III data, EU approvals and high‑margin oncology revenue growth.